The Effect of an Augmented Reality Game on Pain, Fear, and Care Satisfaction Levels During Allergy Testing in Children Aged 4-12 Years
NCT ID: NCT06986655
Last Updated: 2025-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2023-08-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
H1: The pain level of children undergoing allergy testing in the AR group is lower than that of children in the control group.
H2: The fear level of children undergoing allergy testing in the AR group is lower than that of children in the control group.
H3: The care satisfaction level of children undergoing allergy testing in the AR group is higher than that of children in the control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Augmented Reality on Pain, Anxiety, and Fear in Children During Blood Collection
NCT06575816
The Effect of Virtual Reality (VR) on Skin Prick Test Related Pain and Fear in Children
NCT06421779
Effect of Virtual Reality Headsets on Fear Anxiety and Physiological Parameter in Skin Prick Test
NCT06401408
Effect of Virtual Reality and Serious Games on Pain, Fear, Anxiety, and Satisfaction During Skin Prick Testing in Children
NCT06993259
Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children
NCT05378581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Arm (AR Group)
Children in this group will be exposed to an augmented reality game during the allergy testing procedure. The game will be used as a distraction method to potentially reduce pain and fear, and enhance care satisfaction.
Augmented Reality
In this intervention children will play an augmented reality game during the allergy testing procedure. The game will be used as a distraction method to potentially reduce pain and fear, and enhance care satisfaction.
Control Arm (Standard Care Group)
Children in this group will undergo allergy testing following standard clinical procedures without any AR intervention or distraction.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Augmented Reality
In this intervention children will play an augmented reality game during the allergy testing procedure. The game will be used as a distraction method to potentially reduce pain and fear, and enhance care satisfaction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled to undergo an allergy test.
* No visual impairments that would interfere with the use of augmented reality -applications.
* No use of anxiolytic or analgesic medications within the last six hours.
* Willing to participate in the study, with parental/legal guardian consent as applicable.
Exclusion Criteria
* Not scheduled for an allergy test.
* Presence of visual impairments.
* Use of anxiolytic or analgesic medications within the last six hours.
* Unwilling to participate in the study or lacking informed consent.
4 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Koç University Hospital
UNKNOWN
Koç University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enes Simsek
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Remziye Semerci Şahin, Assistant professor
Role: STUDY_DIRECTOR
Koç University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Koç University Hospital
Istanbul, Zeytinburnu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023.206.IRB1.068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.